US Pharma MarketingThe post First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system appeared first on Medical Device Network.
First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational EV-ICD system. The trial will enrol around 280 patients at up to 40 locations in the US and the Netherlands. AtaCor Medical’s EV-ICD Atala lead and delivery tool. Credit: AtaCor Medical / PRNewswire. AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational extravascular implantable cardioverter-defibrillator (EV-ICD) system. The study is designed for patients who need a standard ICD but do not require chronic pacing for slow heart rhythms. Combine business intelligence and editorial excellence to…
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational EV-ICD system.
Source: Medical Device Network